Analysis of Donor Factors for Non–Heart-Beating Donors With Regard to Cadaveric Kidney Transplantation in the Western Region of Japan N. Nakamura, M.

Slides:

Advertisements

Similar presentations

1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 4.1 Chapter 4.

Advertisements

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell

ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Leading Efforts to Increase Organ Donation Through Professionalization of Organ Procurement Organizations and Establishment of Organ and Tissue Donor Registries.

Endovascular Treatment of Vertebral Artery Stenosis

Organ Trafficking: Global Solutions for a Global Problem

Effect of Verapamil and Lidocaine on TRPM and NaV1

Quantifying Mesenchymal Stem Cells in the Mononuclear Cell Fraction of Bone Marrow Samples Obtained for Cell Therapy M. Alvarez-Viejo, Y. Menendez-Menendez,

Donor age still matters in liver transplantation

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Volume 57, Issue 5, Pages (May 2000)

Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis

Renal Function Testing

Diagnosis and Management of Chronic Kidney Disease

Colin R. Lenihan, MB, BCh, BAO, Jane C. Tan, MD, PhD

Outcomes of cardiac surgery in chronic kidney disease

Are patients willing to travel for better ovarian cancer care?

Living donor liver transplantation: is the hype over?

Recent Advances in Liver Transplantation

What lessons have we learned in pediatric liver transplantation?

Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox” Carl J. Lavie, MD, Richard V.

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

Quiz Page July 2009 American Journal of Kidney Diseases

Quiz American Journal of Kidney Diseases

The Global Role of Kidney Transplantation

Jayme E. Locke, MD, MPH American Journal of Kidney Diseases

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Volume 62, Issue 3, Pages (March 2015)

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

End-stage renal disease in living kidney donors

Organ transplantation: historical perspective and current practice

Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies Krista L. Lentine, MD, MS, Frank P. Hurst,

CPR 1.2.: Evaluation of Anemia in CKD

Volume 62, Issue 1, Pages (July 2002)

Antibiotic De-Escalation

American Journal of Kidney Diseases

Organ Trafficking: Global Solutions for a Global Problem

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Volume 17, Issue 2, Pages (February 1950)

Transplant glomerulopathy as a cause of late graft loss

Counteracting progression of renal disease: A look into the future

Current Concepts in Hemodialysis Vascular Access Infections

Volume 58, Issue 6, Pages (December 2000)

Liver transplantation in children

Volume 84, Issue 4, Pages (October 2013)

Volume 87, Issue 5, Pages (May 2015)

Homocysteine, renal function, and risk of cardiovascular disease

Andris Kazmers, MD, Manuel D. Cerqueira, MD, R.Eugene Zierler, MD

Long-term survival in renal transplant recipients with graft function

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

The Iranian model of living renal transplantation

Stephen P. Mcdonald, Graeme R. Russ Kidney International

Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System Supreet Sethi, Reiad Najjar, Alice Peng, James.

August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD

Internet Organ Solicitation, Explained

Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease Sandra Amaral, Blayne A.

Mammen Chandy Biology of Blood and Marrow Transplantation

Heart transplantation in patients with previous cardiac operations:

Supportive care for patients with renal disease: Time for action

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 55, Issue 2, Pages (February 1999)

International practices of organ donation

The Journal of Thoracic and Cardiovascular Surgery

Thirty years of cardiac transplantation at stanford university

Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis Nauman Siddiqi, Maureen A. McBride,

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Number of Donors in Australia

Presentation transcript:

Analysis of Donor Factors for Non–Heart-Beating Donors With Regard to Cadaveric Kidney Transplantation in the Western Region of Japan N. Nakamura, M. Tanaka, M. Tsukamoto, Y. Shimano, M. Yasuhira, J. Ashikari Transplantation Proceedings Volume 49, Issue 1, Pages 16-25 (January 2017) DOI: 10.1016/j.transproceed.2016.11.004 Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 1 Annual change of the number of organ donations. Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 2 Patients and graft survival (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 3 Age distribution of non–heart-beating donors (N = 304). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 4 Analysis of graft survival categorized by donor age (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 5 Analysis of graft survival stratified by donor age (under 70 vs over 70) (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 6 Cause of death in non–heart-beating donors (N = 304). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 7 Graft survival of analysis stratified by cause of death (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 8 Graft survival of analysis stratified by cause of death (cardiovascular disease vs other diseases) (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 9 Graft survival of analysis stratified by cause of death (atherosclerotic disease vs other disease) (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 10 Graft survival of analysis stratified by final serum creatinine before donation (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 11 Graft survival of analysis stratified by duration of anuria (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 12 Graft survival of analysis stratified by presence of cannulation (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 13 Graft survival of analysis stratified by WIT (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 14 Graft survival of analysis stratified by WIT (WIT under 30 minutes vs over 30 minutes) (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions

Fig 15 Graft survival of analysis stratified by TIT (TIT under 24 hours vs over 24 hours) (N = 589). Transplantation Proceedings 2017 49, 16-25DOI: (10.1016/j.transproceed.2016.11.004) Copyright © 2016 Elsevier Inc. Terms and Conditions